Table 5.
Grouped-level disorder | Count | Overall prevalence | 95% CIa | Female prevalence % | Male prevalence % | P-value |
---|---|---|---|---|---|---|
Cutaneous | 399 | 17.9 | 16.3–19.6 | 16.0 | 19.9 | 0.018 |
Enteropathy | 372 | 16.7 | 15.2–18.3 | 14.5 | 18.9 | 0.006 |
Aural | 364 | 16.3 | 14.8–17.9 | 16.0 | 16.7 | 0.652 |
Upper respiratory tract (URT) | 282 | 12.7 | 11.3–14.1 | 10.0 | 15.2 | < 0.001 |
Ophthalmological | 234 | 10.5 | 9.3–11.9 | 9.3 | 11.7 | 0.073 |
Nail disorder | 119 | 5.3 | 4.4–6.4 | 4.2 | 6.5 | 0.017 |
Musculoskeletal | 105 | 4.7 | 3.9–5.7 | 4.2 | 5.3 | 0.239 |
Parasite infestation | 98 | 4.4 | 3.6–5.3 | 4.2 | 4.6 | 0.676 |
Anal sac disorder | 85 | 3.8 | 3.1–4.7 | 3.9 | 3.8 | 0.859 |
Undesirable behaviour | 74 | 3.3 | 2.6–4.2 | 1.5 | 5.1 | < 0.001 |
Traumatic injury | 68 | 3.1 | 2.4–3.9 | 2.5 | 3.6 | 0.142 |
Lower respiratory tract | 53 | 2.4 | 1.8–3.1 | 1.7 | 3.0 | 0.043 |
Cardiac | 52 | 2.3 | 1.7–3.0 | 1.8 | 2.9 | 0.082 |
Mass lesion | 45 | 2.0 | 1.5–2.7 | 2.5 | 1.5 | 0.084 |
Dental | 43 | 1.9 | 1.4–2.6 | 2.0 | 1.9 | 0.961 |
The P-value reflects prevalence comparison between females and males
aCI confidence interval